Cite
MLA Citation
J Vansteenkiste et al.. “Current status of immune checkpoint inhibition in early-stage NSCLC.” Annals of oncology, vol. 30, 2019, pp. 1244–1253. http://access.bl.uk/ark:/81055/vdc_100092355199.0x000033
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
J Vansteenkiste et al.. “Current status of immune checkpoint inhibition in early-stage NSCLC.” Annals of oncology, vol. 30, 2019, pp. 1244–1253. http://access.bl.uk/ark:/81055/vdc_100092355199.0x000033